Dumalagan, Mary Joy .
HRN: 26-71-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2025
CEFUROXIME 1.5GM (VIAL)
04/08/2025
04/09/2025
IVT
1.5 Grams
On Call To Or Then Q 8
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes